| 000 | 01776nam a2200265Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625153851.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-12355 | ||
| 245 | 1 | 0 | _aConvergence and reorientation via open innovation: the emergence of nutraceuticals |
| 490 | 0 | _vTechnology Analysis & Strategic Management, 22(5), p.571-592, 2010 | |
| 520 | 3 | _aThe use of networked organisational arrangements to conduct exchanges is one of the most distinctive features of high-tech research-intensive industries. Advances in biotechnology and genomics research have enabled a generic technology platform that has fuelled a more 'open' approach to innovation and learning. This relies on collaborations between networked partners and allows for the convergence and reorientation of traditional sectors. This paper lends support to the view that some technologies can trigger a higher system level innovation, that is, in addition to the inter-firm level, an inter-industrial and inter-institutional level convergence and re-orientation process. This paper explores how this phenomenon is being witnessed in the pharmaceutical and food sectors and fast becoming a dominant logic in the emerging nutraceuticals industry. | |
| 650 | 1 | 4 | _aTECHNOLOGY MANAGEMENT |
| 650 | 1 | 4 | _aNEW PRODUCT DEVELOPMENT |
| 650 | 1 | 4 | _aKNOWLEDGE MANAGEMENT |
| 650 | 1 | 4 | _aINNOVATION STRATEGY |
| 650 | 1 | 4 | _aTECHNOLOGY AND INNOVATION STUDIES |
| 650 | 1 | 4 | _aPHARMACEUTICAL INDUSTRY |
| 700 | 1 | 2 | _aSiedlok, F. |
| 700 | 1 | 2 | _aSmart, P. |
| 700 | 1 | 2 | _aGupta, A. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1hZu5Uc6N_M0H9Jcggkvs4Y48T5RpF-j9/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c46563 _d46563 |
||